"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
Descriptor ID |
D011379
|
MeSH Number(s) |
E01.789
|
Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 22 | 22 |
1995 | 0 | 22 | 22 |
1996 | 0 | 27 | 27 |
1997 | 0 | 22 | 22 |
1998 | 0 | 31 | 31 |
1999 | 0 | 35 | 35 |
2000 | 0 | 55 | 55 |
2001 | 0 | 32 | 32 |
2002 | 0 | 29 | 29 |
2003 | 1 | 53 | 54 |
2004 | 0 | 56 | 56 |
2005 | 0 | 65 | 65 |
2006 | 0 | 49 | 49 |
2007 | 0 | 78 | 78 |
2008 | 1 | 89 | 90 |
2009 | 1 | 90 | 91 |
2010 | 0 | 92 | 92 |
2011 | 0 | 126 | 126 |
2012 | 0 | 125 | 125 |
2013 | 0 | 143 | 143 |
2014 | 1 | 122 | 123 |
2015 | 1 | 134 | 135 |
2016 | 1 | 131 | 132 |
2017 | 2 | 140 | 142 |
2018 | 4 | 142 | 146 |
2019 | 1 | 163 | 164 |
2020 | 1 | 140 | 141 |
2021 | 1 | 97 | 98 |
2022 | 0 | 45 | 45 |
2023 | 0 | 44 | 44 |
2024 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia. Leuk Lymphoma. 2024 Jan; 65(1):69-77.
-
Clinical Utility and Benefits of Comprehensive Genomic Profiling in Cancer. J Appl Lab Med. 2024 Jan 03; 9(1):76-91.
-
5-Hydroxymethylcytosine Profiling of Cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk Neuroblastoma. JCO Precis Oncol. 2024 Jan; 8:e2300297.
-
Sepsis-associated acute kidney injury-treatment standard. Nephrol Dial Transplant. 2023 Dec 20; 39(1):26-35.
-
CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition. J Clin Oncol. 2024 Feb 01; 42(4):467-480.
-
Factors influencing diagnostic accuracy among intensive care unit clinicians - an observational study. Diagnosis (Berl). 2024 Feb 01; 11(1):31-39.
-
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG). Leukemia. 2024 01; 38(1):45-57.
-
The Revised Baux Score as a Predictor of Burn Mortality: A Systematic Review and Meta-Analysis. J Burn Care Res. 2023 11 02; 44(6):1278-1288.
-
Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories. Blood Adv. 2023 10 24; 7(20):6048-6054.
-
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma. Pediatr Blood Cancer. 2024 Jan; 71(1):e30735.